pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Bi-specific T-cell engager (BiTE) · news · pharmadog
← back to Bi-specific T-cell engager (BiTE)
News · Bi-specific T-cell engager (BiTE)
4
stories
18h
CDC releases latest life expectancy data
stat
8d
Regeneron ends eye disease trial for anti-CD3 antibody following safety review
fiercebiotech
20d
Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027
fiercebiotech
Jul 23, 26
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
fiercebiotech
